주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
Updated : Friday, March 29, 2024, 22:07
Home
Login
Sign in
한국어
National
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
Macro-Economics
Trade
Foreign Exchanges
Industries
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
Company & Stock Tracking
Market Trend & Outlook
Finance
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
Science
New Tech
Blockchain
ESG
Environment
Social
Governance
Event
Exhibitions
Conferences
People
K-Culture
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
Editorials
Contributions
Who's Who
기사검색
검색
All articles
List
Subject Type
Summary Type
Photo Type
Samsung Bioepis Announces Results of Humira Biosimilar Interchangeability Study in US
이미지기사
Healthcare & Bio
Jasmine Choi
03.11 12:06
Samsung Bioepis Receives European Recommendation for Stelara Biosimilar Pyzchiva
이미지기사
Healthcare & Bio
Choi Mun-hee
02.26 08:32
Samsung to Hire Massive Amounts of Foreign Professionals for R&D
이미지기사
ICT
Jasmine Choi
02.22 18:26
Samsung Bioepis, Celltrion Entangled in Patent Disputes with Original Pharmaceutical Companies
이미지기사
Healthcare & Bio
Choi Mun-hee
02.02 14:20
Samsung Biologics Surpasses 1 Trillion Won in Annual Operating Profit for 1st Time
이미지기사
Healthcare & Bio
Jasmine Choi
01.25 12:58
Samsung Signs MOU with US-based Venture Capital Firm
이미지기사
Construction
Jasmine Choi
01.10 14:37
IFEZ Accelerates Efforts to Attract Milner Research Institute of Cambridge University
이미지기사
Science
Jasmine Choi
2023.11.28 15:21
[Samsung Biologics] EV/EBITDA enters a reasonable level
이미지기사
Company & Stock Tracking
Pyeongkuk Park
2023.10.26 15:26
Samsung Bioepis, Celltrion Both Confirm Efficacy of Stelara Biosimilars
이미지기사
Healthcare & Bio
Jung Min-hee
2023.10.13 11:26
Samsung Bioepis Considering Acquisition of Biogen’s Biosimilars Business in US
이미지기사
Industries
Jasmine Choi
2023.08.02 18:18
Biopharmaceuticals Added to National Strategic Technology List, Eligible for Up to 35% Tax Deduction
이미지기사
Industries
Kim Eun-jin
2023.07.28 11:08
Samsung Bioepis, Humira Biosimilar Listed by US PBM Prime
이미지기사
Industries
Jasmine Choi
2023.07.14 10:42
Samsung Bioepis, Celltrion to Target US$20 Billion US Humira Similar Market
이미지기사
Industries
Jung Suk-yee
2023.07.03 09:38
Samsung Biologics Faced with Patent Lawsuit from Regeneron in US
이미지기사
Industries
Yoon Young-sil
2023.05.19 11:59
Samsung Chairman Talks Promotion with Pharma Giants, Bio-venture Startups in US
이미지기사
Industries
Jung Min-hee
2023.05.08 10:49
Deferring of 1H23 sales to 2H23 to have no impact on EV
이미지기사
Finance
Pyeongkuk Park
2023.04.10 17:48
South Korean New Drugs Enjoying Sales Growth in the U.S.
이미지기사
Lifestyle
Choi Moon-hee
2023.02.27 11:50
Samsung Biologics: Ushering in Era of Over KRW3tn in Annual Revenue
이미지기사
Finance
Kim Tae-hee
2023.01.31 08:43
Samsung Biologics: All Eyes on Plant 5 and Samsung Bioepis
이미지기사
Finance
Lee Dong-gun
2023.01.04 09:32
Samsung Biologics: Plant #4 to Contribute to Growth after Preparation Period in 2023
이미지기사
Finance
Park Pyeong-kuk
2023.01.04 09:23
처음
1
2
3
4
5
다음
다음
끝
위로
모바일버전
All articles
National
전체
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
전체
Macro-Economics
Trade
Foreign Exchanges
Industries
전체
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
전체
Company & Stock Tracking
Market Trend & Outlook
Finance
전체
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
전체
Science
New Tech
Blockchain
ESG
전체
Environment
Social
Governance
Event
전체
Exhibitions
Conferences
People
K-Culture
전체
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
전체
Editorials
Contributions
Who's Who
전체메뉴닫기